Ireland plant with 100 workers on Sun's list for sale or closure

In a new wrinkle in Sun Pharmaceutical's plans for merging Ranbaxy Laboratories, the Indian company is putting together a list of plants that it will sell or close and among them is a facility in Tipperary, Ireland. The 100 workers there were called into a meeting and told the fate of the facility should be determined by early next year. A spokesman for the company said on Wednesday that "decisions are being made to either close or divest some of its manufacturing facilities. Currently, the Ireland facility has been identified for divestment." Story | More

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.